Cardiovascular Risk in People Older Than 55 Years and Cognitive Performance at 5 Years
NCT ID: NCT03925844
Last Updated: 2021-02-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
965 participants
OBSERVATIONAL
2014-01-31
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Impairment and Cardiovascular Risk in Older
NCT01327196
Cardiovascular Risk Factors and Cognitive Trajectories
NCT05441865
Personalised Medicine in the Identification of Preclinical Cognitive Impairment. Development of a Predictive Risk Model
NCT06114290
Frailty Assessment and Treatment Strategies in the Elderly at Risk of Functional Decline in the Community
NCT03591055
Risk Prediction and Its Intelligent Assessment for Cognitive Impairment Among Community-dwelling Older Adults
NCT05385874
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Classification according to the cardiovascular risk
All patients are cognitively assessed at the beginning of the study and their cardiovascular risk is calculated. After 5 years of follow-up, patients are re-evaluated cognitively and their cardiovascular risk is recalculated.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* to have signed informed consent
* to have done the neuropsicological assessment
Exclusion Criteria
55 Years
74 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gerencia de Atención Primaria, Madrid
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ester Tapias Merino
Clinical researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ester Tapias-Merino, MD
Role: PRINCIPAL_INVESTIGATOR
Gerencia de Atención Primaria, Madrid
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gerencia Atencion Primaria
Madrid, , Spain
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Hernandez-Gallego J, Llamas-Velasco S, Bermejo-Pareja F, Vega S, Tapias-Merino E, Rodriguez-Sanchez E, Boycheva E, Serrano JI, Gil-Garcia JF, Trincado R, Sanchez-Rodrigo JV, Cacho J, Contador I, Garcia-Ptacek S, Sierra-Hidalgo F, Cubo E, Carro E, Villarejo-Galende A, Garcia Garcia-Patino R, Benito-Leon J. Neurological Disorders in Central Spain, Second Survey: Feasibility Pilot Observational Study. JMIR Res Protoc. 2019 Jan 10;8(1):e10941. doi: 10.2196/10941.
Tapias-Merino E, De Hoyos-Alonso MDC, Contador-Castillo I, Rodriguez-Sanchez E, Sanz-Cuesta T, Becerro-Munoz CM, Hernandez-Gallego J, Vega-Quiroga S, Bermejo-Pareja F; NEDICES2-RISK Group. Cardiovascular risk in subjects over 55 years of age and cognitive performance after five years. NEDICES2-RISK study. Study protocol. PLoS One. 2022 Nov 28;17(11):e0274589. doi: 10.1371/journal.pone.0274589. eCollection 2022.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Informed Consent Form
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PI18/00522
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.